1 in 5 Australians over the age of 45 complain of chronic pain (a major symptom of EDS, hEDS & HSD)
Up to 90% of HSD, hEDS and EDS patients present to GPs and physios with pain as their first symptom
More than 50% of patients with EDS and hEDS report clinician-related patient traumatisation and up to 90% felt invalidated by their clinicians
More than 50% of patients with Autism Spectrum also are hypermobile
Up to 46% of children with EDS and HSD are also diagnosed with ADHD
EDS, hEDS, and HSD disproportionately impact females, with 80-90% of cases occurring in women
57% of patients with chronic pain in Australia rely on pain medications/analgesics
1 in 5 Australians over the age of 45 complain of chronic pain (a major symptom of EDS, hEDS & HSD)
Up to 90% of HSD, hEDS and EDS patients present to GPs and physios with pain as their first symptom
More than 50% of patients with EDS and hEDS report clinician-related patient traumatisation and up to 90% felt invalidated by their clinicians
More than 50% of patients with Autism Spectrum also are hypermobile
Up to 46% of children with EDS and HSD are also diagnosed with ADHD
EDS, hEDS, and HSD disproportionately impact females, with 80-90% of cases occurring in women
57% of patients with chronic pain in Australia rely on pain medications/analgesics
1 in 5 Australians over the age of 45 complain of chronic pain (a major symptom of EDS, hEDS & HSD)
Up to 90% of HSD, hEDS and EDS patients present to GPs and physios with pain as their first symptom
More than 50% of patients with EDS and hEDS report clinician-related patient traumatisation and up to 90% felt invalidated by their clinicians
More than 50% of patients with Autism Spectrum also are hypermobile
Up to 46% of children with EDS and HSD are also diagnosed with ADHD
EDS, hEDS, and HSD disproportionately impact females, with 80-90% of cases occurring in women
57% of patients with chronic pain in Australia rely on pain medications/analgesics
1 in 5 Australians over the age of 45 complain of chronic pain (a major symptom of EDS, hEDS & HSD)
Up to 90% of HSD, hEDS and EDS patients present to GPs and physios with pain as their first symptom
More than 50% of patients with EDS and hEDS report clinician-related patient traumatisation and up to 90% felt invalidated by their clinicians
More than 50% of patients with Autism Spectrum also are hypermobile
Up to 46% of children with EDS and HSD are also diagnosed with ADHD
EDS, hEDS, and HSD disproportionately impact females, with 80-90% of cases occurring in women
57% of patients with chronic pain in Australia rely on pain medications/analgesics
If you are experiencing a medical emergency or an acute illness, please seek immediate assistance from a qualified medical professional or contact emergency services on Triple Zero (000) and ask for an ambulance.
Hypermobility refers to joints that move beyond the normal range of motion. While some individuals with hypermobility experience no symptoms, others may suffer from pain, fatigue, and other health conditions. When hypermobility is accompanied by symptoms such as pain, fatigue, and joint instability, it is referred to as symptomatic hypermobility. Two primary conditions associated with symptomatic hypermobility are hypermobility spectrum disorders (HSD) or Ehlers-Danlos syndrome (EDS).
Understanding the link between hypermobility and these symptoms is crucial for effective
management and improving quality of life. If you have any specific questions or need more details, feel free to ask
Hypermobility refers to when someone’s joints bend further than most people. It is excessive (hyper)- movement (mobility) of the joints of the human body. People were often called double- jointed. Not all people with hypermobility have pain or other symptoms, which is called asymptomatic hypermobility. Many health disorders, such as fibromyalgia, arthritis, autism, and Ehlers-Danlos Syndrome, can involve hypermobility. Therefore, it is crucial to medically investigate the cause of your hypermobility, especially if you have other health conditions and symptoms.
Hypermobility Spectrum Disorder (HSD) is a diagnosis given when hypermobility causes symptoms like ongoing pain or joint instability but does not meet the criteria for a specific genetic condition like Ehlers-Danlos Syndrome (EDS). HSD can present with other body wide symptoms that impacts the function of a person’s everyday life. HSD is recognised as a distinct disorder requiring management and care.
Hypermobile Ehlers-Danlos Syndrome (hEDS) is the most common EDS subtype. It shares many features with HSD, including hypermobile and often painful joints, but hEDS has stricter diagnostic criteria and a genetic basis that researchers are still working to identify.
Ehlers-Danlos Syndrome (EDS) is a group of genetic connective tissue disorders affecting the skin, joints, and other tissues. There are 13 subtypes, each with specific genetic causes and
clinical features.
Proper differential diagnosis is crucial for effective management and in some cases, lifesaving
interventions.
Growing up with Hypermobility or Ehlers-Danlos Syndrome (EDS) can present a variety of unique challenges and experiences. Here are some signs that might indicate you grew up with these conditions:
These signs highlight the diverse and often challenging experiences of growing up with hypermobility or EDS. If you have any more questions or need further details, see our detailed articles and references at….
Hypermobility Health Connect® offers specialised education and professional development designed to equip allied health and medical professionals with the essential knowledge and practical skills to recognise, confidently & accurately diagnose, and effectively manage individuals with Hypermobility, Hypermobility Spectrum Disorder (HSD), and Hypermobile Ehlers-Danlos Syndrome (hEDS).
Led by Pauline Slater(B.App.Sc (Physio), M.Ed., MAPA (Pain & Paediatrics), MAPS, HMSA Member, EDS Society Affiliate, POTS Foundation Member), our programs include face-to-face workshops, presentations, live webinars, and mentoring to deliver evidence-based, hands-on learning. This integrated approach to education and training supports enhanced clinical outcomes.











© 2025 All rights reserved to Hypermobility Health PTY LTD (ABN 18 679 956 480)
Use of this website constitutes acceptance of our Privacy Statement and Terms & Conditions.
Designated logos, trademarks and brands are the property of their respective owners. HYPERMOBILITY HEALTH CONNECT® is a trademark of Hypermobility Health PTY LTD.